Amundi’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.6M | Buy |
226,257
+209,910
| +1,284% | +$33.1M | 0.01% | 615 |
|
|
2025
Q1 | $2.3M | Sell |
16,347
-53,919
| -77% | -$7.6M | ﹤0.01% | 1116 |
|
|
2024
Q4 | $13.2M | Buy |
70,266
+16,599
| +31% | +$3.12M | ﹤0.01% | 799 |
|
|
2024
Q3 | $10M | Sell |
53,667
-4,643
| -8% | -$867K | ﹤0.01% | 847 |
|
|
2024
Q2 | $11.7M | Buy |
58,310
+608
| +1% | +$122K | ﹤0.01% | 801 |
|
|
2024
Q1 | $13.1M | Sell |
57,702
-12,888
| -18% | -$2.93M | 0.01% | 781 |
|
|
2023
Q4 | $15.2M | Buy |
70,590
+25,896
| +58% | +$5.57M | 0.01% | 762 |
|
|
2023
Q3 | $8.54M | Sell |
44,694
-22,543
| -34% | -$4.31M | ﹤0.01% | 868 |
|
|
2023
Q2 | $14M | Sell |
67,237
-109,173
| -62% | -$22.8M | 0.01% | 770 |
|
|
2023
Q1 | $34.5M | Buy |
176,410
+63,983
| +57% | +$12.5M | 0.02% | 593 |
|
|
2022
Q4 | $27.8M | Sell |
112,427
-25,753
| -19% | -$6.36M | 0.02% | 632 |
|
|
2022
Q3 | $29.8M | Sell |
138,180
-55,123
| -29% | -$11.9M | 0.02% | 613 |
|
|
2022
Q2 | $40.7M | Buy |
193,303
+49,086
| +34% | +$10.3M | 0.03% | 483 |
|
|
2022
Q1 | $43.6M | Buy |
144,217
+4,915
| +4% | +$1.48M | 0.03% | 493 |
|
|
2021
Q4 | $49M | Sell |
139,302
-51,448
| -27% | -$18.1M | 0.03% | 481 |
|
|
2021
Q3 | $78.7M | Buy |
190,750
+35,082
| +23% | +$14.5M | 0.06% | 342 |
|
|
2021
Q2 | $57.6M | Buy |
+155,668
| New | +$57.6M | 0.04% | 409 |
|